Acute iliofemoral DVT with May-Thurner anatomy: lysis, filter or anticoagulation alone?
A 42-year-old woman presents 6 days after a 12-hour flight with a swollen, painful left leg. The leg is tense and dusky, and she has severe pain at rest; distal pulses are present but reduced. Ultrasound shows occlusive thrombus from the common iliac vein to the common femoral vein. CT confirms May-Thurner anatomy with compression of the left common iliac vein by the right common iliac artery. She has no cancer, no prior VTE, normal renal function and no bleeding history. She takes a combined oral contraceptive. Platelets 240 × 10^9/L, INR 1.0, haemoglobin 128 g/L. She is haemodynamically stable. The vascular team has started therapeutic low-molecular-weight heparin. The patient asks whether she will need a stent and how long she will be anticoagulated. The on-call IR fellow suggests catheter-directed thrombolysis, but the consultant is concerned about bleeding and post-thrombotic syndrome.
1. Would you offer catheter-directed thrombolysis or pharmacomechanical thrombectomy? Justify your decision using symptom duration, extent of thrombus and bleeding risk.
Read the worked answer
She has a severe, extensive iliofemoral DVT with a short history (6 days), low bleeding risk and good functional status. Anticoagulation alone is standard, but it leaves a high risk of post-thrombotic syndrome in iliofemoral disease. Guidelines support considering catheter-directed therapy in selected patients with severe symptoms, symptom duration <14 days and low bleeding risk; the evidence is not uniformly positive, so this is a shared decision. Pharmacomechanical thrombectomy may shorten lytic exposure and reduce the lytic dose, which is attractive here.
I would offer catheter-directed therapy after consent, with a plan for single-session or short-duration pharmacomechanical thrombectomy, not prolonged high-dose lysis. If she declines or bleeding risk changes, therapeutic anticoagulation and compression remain appropriate. The presence of May-Thurner anatomy makes a stent likely after thrombus clearance, but stenting is not the first step.
2. What is the role of an IVC filter in this patient?
Read the worked answer
There is no routine indication for an IVC filter. She is haemodynamically stable, has no symptomatic PE and can be anticoagulated. Filters are indicated when anticoagulation is contraindicated or fails despite adequate anticoagulation, or occasionally as a temporary adjunct when a large amount of iliofemoral thrombus is being manipulated and anticoagulation cannot be used. Free-floating thrombus alone is not an indication.
If catheter-directed therapy is performed, a retrievable filter is not mandatory; it may be considered only if there is a major contraindication to anticoagulation or a very large, mobile iliac thrombus and the team judges embolic risk to be high. If placed, document a retrieval plan. In this patient, I would not place a filter.
3. If you proceed, describe the sequence of intervention and when you would stent the iliac vein.
Read the worked answer
Obtain access, usually via the popliteal or common femoral vein, and cross the occluded segment with a guidewire. Perform preliminary venography and then thrombus removal with pharmacomechanical or aspiration thrombectomy, using a small amount of lytic if needed. Treat inflow and outflow. After thrombus clearance, perform venography and intravascular ultrasound if available to assess the underlying May-Thurner stenosis. Do not stent until the thrombus is cleared, because stenting through fresh thrombus risks early occlusion. If a residual stenosis or web is present, predilate and place a dedicated self-expanding venous stent sized to the normal iliac vein (often 14–16 mm), avoiding jailing of the contralateral common iliac vein. Continue anticoagulation for at least 3–6 months, with compression and follow-up imaging.